Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Wood

Showing results (11-20 of 157) with videos related to

Pageof 16
Sort By:
The Journal of Urology|November 13, 2012
Re: Neoadjuvant and adjuvant chemotherapy for locally advanced bladder carcinoma: development of novel bladder preservation approach, osaka medical college regimenDavid P Wood
The Journal of Urology|January 14, 2014
Re: role of marker lesion when applying intravesical instillations of IL-2 for non-muscle-invasive bladder cancer comparison of the therapeutic effects in two pilot studiesDavid P Wood
The Journal of Urology|April 13, 2012
Re: the role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic aminesDavid P Wood
The Journal of Urology|February 14, 2012
Re: phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75David P Wood
The Journal of Urology|October 13, 2012
Re: Maximizing intravesical therapy options: is there an advantage to the administration of perioperative mitomycin C prior to an induction course of BCG?David P Wood
The Journal of Urology|May 14, 2013
Re: Association of polymorphisms in oxidative stress genes with clinical outcomes for bladder cancer treated with Bacillus Calmette-GuérinDavid P Wood
The Journal of Urology|December 14, 2012
Re: Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative studyDavid P Wood
The Journal of Urology|April 9, 2013
Re: a phase 2 cancer chemoprevention biomarker trial of isoflavone g-2535 (genistein) in presurgical bladder cancer patientsDavid P Wood
The Journal of Urology|January 14, 2014
Re: final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenanceDavid P Wood
The Journal of Urology|April 18, 2009
When does lymphadenectomy improve survival of patients with genitourinary malignancies?David P Wood
Pageof 16

Showing results (11-20 of 157) with videos related to

Sort By:
Pageof 16
The Journal of Urology|November 13, 2012
Re: Neoadjuvant and adjuvant chemotherapy for locally advanced bladder carcinoma: development of novel bladder preservation approach, osaka medical college regimenDavid P Wood
The Journal of Urology|January 14, 2014
Re: role of marker lesion when applying intravesical instillations of IL-2 for non-muscle-invasive bladder cancer comparison of the therapeutic effects in two pilot studiesDavid P Wood
The Journal of Urology|April 13, 2012
Re: the role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic aminesDavid P Wood
The Journal of Urology|February 14, 2012
Re: phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75David P Wood
The Journal of Urology|October 13, 2012
Re: Maximizing intravesical therapy options: is there an advantage to the administration of perioperative mitomycin C prior to an induction course of BCG?David P Wood
The Journal of Urology|May 14, 2013
Re: Association of polymorphisms in oxidative stress genes with clinical outcomes for bladder cancer treated with Bacillus Calmette-GuérinDavid P Wood
The Journal of Urology|December 14, 2012
Re: Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative studyDavid P Wood
The Journal of Urology|April 9, 2013
Re: a phase 2 cancer chemoprevention biomarker trial of isoflavone g-2535 (genistein) in presurgical bladder cancer patientsDavid P Wood
The Journal of Urology|January 14, 2014
Re: final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenanceDavid P Wood
The Journal of Urology|April 18, 2009
When does lymphadenectomy improve survival of patients with genitourinary malignancies?David P Wood
Pageof 16